The Centers for Medicare & Medicaid Services (CMS) has identified four quality measures impacted by the Oct. 1 update to the ICD-10-CM code set. Providers submitting performance data under the Merit-based Incentive Payment System (MIPS) should limit data collection to the first nine months (Jan. 1 – Oct. 1) of the performance period for these quality measures.

Impacted Measures

The four quality measures affected by the 2019 ICD-10-CM code set update are registry measures stewarded by the American Academy of Dermatology:

Quality No.        Measure Title

137 Melanoma:    Continuity of Care – Recall System

138 Melanoma:    Coordination of Care

224 Melanoma:    Overutilization of Imaging Studies in Melanoma

440 Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC):

Biopsy Reporting Time – Pathologist to Clinician

Because these are registry measures, MIPS eligible clinicians should work with their qualified registries and qualified clinical data registries to restrict the denominator-eligible population of only the impacted measures to the first nine months of the 2018 performance period.

ICD-10 Codes Impacting Measures

These quality measures are significantly impacted due to 10 percent or more denominator-applicable ICD-10-CM codes being deleted or added for the annual update on Oct. 1.

Quality No. ICD-10-CM Code Changes

Source:
https://www.cms.gov/Medicare/Quality-Payment-Program/Resource-Library/2018-Quality-Measures-Impacted-by-ICD-10.pdf